Pharma Sources Insight第十四期 | 全球原料藥采購趨勢

熱門推薦： Pharma Sources Insight , API , OOS , AI ,

作者：PSI 來源：CPHI制藥在線

2025-08-01

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world.

二維碼

掃描二維碼開始閱讀

Scan to preview the contents.

https://flbook.com.cn/c/FKKL7kCsVr

Pharma Sources Insight July 2025 focuses on the following topics:

FROM THE EDITOR

-FDA Guidance - Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production

BRAND STORY

-ZHUOHE PHARMACEUTICAL GROUP CO., LTD.

GLOBAL PHARMA INDUSTRY

-Orphan Drugs as Strategic Assets: Lifecycle Patterns, Sales Resilience, and Market Impact

-Radioconjugate Therapy: The Approval Process and the Market Landscape

PURCHASING AND SALES STRATEGIES

-Global API Sourcing Trends: Why Quality Antibiotics Matter in 2025

Worth Reading：

Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection

-Who Will Hold the Reins? An Analysis of Drug-Originating Countries for the US Market

DRUG R&D

-Small Molecule Drugs for Obesity: A Scalable, Oral Alternative to Peptide-Based Therapies

Worth Reading：

A Brief Overview of Emerging Target: STEAP

-Artificial Intelligence in Precision Cancer Care: Unlocking the Future of Personalized

PHARMA IN CHINA

-Made-in-China New Drugs: The Game and Breakthrough in the Over - 4 - Billion Market

-Popular Products and Companies at PharmaSources

INDUSTRY INSIGHT

-Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outperform Traditional Production?

Worth Reading：

ESG Related Equipment in Pharmaceutical Industry

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverage on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPHI China.

【往期回顧】

點(diǎn)擊下圖，免費(fèi)閱讀往期內(nèi)容